Clinical Significance of Breast Cancer Molecular Subtypes and Ki67 Expression as a Predictive Value for Pathological Complete Response following Neoadjuvant Chemotherapy: Experience from a Tertiary Care Center in Lebanon

Table 2

Multivariate logistic regression analysis of the correlation between pCR and clinicopathological features.

	HER2 type	Luminal B	Luminal B HER2 type	Triple negative	Luminal A	value
Age						0.339
≤60	11	20	16	6	10
>60	5	2	7	3	2
Menstrual status						0.6060
Premenopause	5	9	7	4	5
Menopause	8	9	14	5	5
T stage						0.1250
T1-T2-T3	9	18	20	7	11
T4	7	4	3	2	1
N stage						0.5960
N0	1	5	4	0	1
N1-N2-N3-Nx	15	17	19	9	11
Ki67						< 0.0001
≤14	6	0	9	0	12
>14	10	22	14	9	0
Response to NCT						0.046
Non-pCR	7	16	8	4	9
pCR	8	5	14	5	3